News | April 13, 2011

2011 Heart Failure Programs Staffing Survey Results Released

April 13, 2011 – The American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and the Heart Failure Society of America (HFSA) have released results of a recent survey to determine the current staffing environment of heart failure (HF) clinics and offices focused on heart transplants.

Historically, there have been no published recommendations about the staffing needs for health centers that focus on either HF and/or heart transplant. The goal of the online, jointly-sponsored survey was to understand the current staffing environments of HF, transplant and mechanical circulatory support device (MCSD) programs in the United States and abroad. The survey was conducted among the memberships of the three organizations who had identified themselves as interested in HF, heart transplant or both.

“Heart failure and transplant/VAD (ventricular assist device) programs around the country and the world are struggling to find the right mix of clinicians and other health professionals to manage this increasing population of patients with heart failure,” said Mariell Jessup, M.D., professor of medicine at the University of Pennsylvania, associate chief – clinical affairs, cardiovascular division of medicine, medical director of the Heart and Vascular Center at Penn Medicine, and lead author of the report. “There is likewise an increased scrutiny of heart failure care, policies and quality in the United States. Thus, there are many questions and concerns about the types of clinicians needed to deliver cost-effective and optimal care.”

According to Jessup, this is the first survey of its kind, to the three organizations’ collective knowledge, and was created to answer questions about appropriate staff numbers for heart failure and transplant programs.

Among the key findings of the survey was the conclusion that staff ratios of physicians, nurses and advanced nurse practitioners stayed the same as programs grew in size. This indicated that the healthcare professionals who provide the highly skilled, specialized and time-consuming care to this population are under constant and intense scrutiny trying to meet quality improvement initiatives and with reduced financial resources. Other survey findings concluded that more VADs are currently being done than heart transplants and the majority of programs currently in place had relatively small staffs.

“This survey attempted to understand what the current staffing levels of such programs are and what the numbers of patients cared for by these staff were,” said Jessup. As a result, she and her colleagues believe that the results can be viewed as the first step towards establishing standards for staff ratios.

The report will be published in the May 17, 2011, issue of the Journal of the American College of Cardiology, as well as Circulation: Journal of the American Heart Association and the May 2011 issue of the Journal of Cardiac Failure.

For more information: http://cardiosource.org/ACC


Related Content

News | Ventricular Assist Devices (VAD)

October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...

Home October 31, 2023
Home
News | Ventricular Assist Devices (VAD)

June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...

Home June 07, 2023
Home
News | Ventricular Assist Devices (VAD)

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...

Home March 01, 2023
Home
News | Ventricular Assist Devices (VAD)

November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...

Home November 02, 2022
Home
News | Ventricular Assist Devices (VAD)

October 18, 2022 — The U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include ...

Home October 18, 2022
Home
News | Ventricular Assist Devices (VAD)

August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling ...

Home August 25, 2022
Home
News | Ventricular Assist Devices (VAD)

August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...

Home August 05, 2022
Home
News | Ventricular Assist Devices (VAD)

June 23, 2022 — Medtronic, Inc. is recalling a single lot of HeartWare HVAD System batteries due to welding defects that ...

Home June 23, 2022
Home
News | Ventricular Assist Devices (VAD)

June 8, 2022 — The U.S. Food and Drug Administration (FDA) has issued a release stating that Medtronic is recalling the ...

Home June 08, 2022
Home
News | Ventricular Assist Devices (VAD)

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
Subscribe Now